Literature DB >> 2104982

Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone Biobreeding rat: implications for generation of an autoimmune T-cell repertoire.

D Bellgrau1, A C Lagarde.   

Abstract

Lymphocytes from diabetes-prone Biobreeding rats consistently fail to generate T-cell-mediated cytotoxicity under conditions where cytotoxic T lymphocyte activity is readily demonstrated in normal rats. The failure is associated with generalized T-cell lymphopenia and marked reduction in the frequency of CD8+ cells. The few remaining CD8+ cells are widely held to be natural killer cells rather than class I major histocompatibility complex-restricted T lymphocytes. In this report we show that a detectable percentage of CD8+ lymphocytes express the T-cell receptor for antigen, thus identifying them as part of the T-cell lineage. The failure of these CD8+ T-cell-receptor-positive T cells to lyse target cells that are susceptible to T-cell mediated cytotoxicity is associated with markedly reduced expression of cell-surface CD8. Targets expressing higher than normal levels of class I major histocompatibility complex target antigen could be lysed, suggesting that reduction in CD8 has decreased T-cell activity for target antigen. We discuss the derivation of T cells that express low levels of CD8 and the role they could play in generating autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104982      PMCID: PMC53253          DOI: 10.1073/pnas.87.1.313

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.

Authors:  R Shimonkevitz; B Luescher; J C Cerottini; H R MacDonald
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

2.  MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses.

Authors:  M J Dallman; M L Thomas; J R Green
Journal:  Eur J Immunol       Date:  1984-03       Impact factor: 5.532

3.  Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry.

Authors:  C W Reynolds; S O Sharrow; J R Ortaldo; R B Herberman
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

4.  The spontaneously diabetic Wistar rat. Metabolic and morphologic studies.

Authors:  A F Nakhooda; A A Like; C I Chappel; F T Murray; E B Marliss
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

5.  The BB diabetic rat. Profound T-cell lymphocytopenia.

Authors:  R Jackson; N Rassi; T Crump; B Haynes; G S Eisenbarth
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

6.  Immunogenetic and immunologic aspects of gliosarcoma growth in rats.

Authors:  S J Geyer; A Landay
Journal:  Lab Invest       Date:  1983-10       Impact factor: 5.662

7.  Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat.

Authors:  M E Elder; N K Maclaren
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Spontaneous diabetes in BB rats: evidence for a T cell dependent immune response defect.

Authors:  D Bellgrau; A Naji; W K Silvers; J F Markmann; C F Barker
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

9.  Prevention of diabetes in BB rats. I. Evidence suggesting a requirement for mature T cells in bone marrow inoculum of neonatally injected rats.

Authors:  J Scott; V H Engelhard; R T Curnow; D C Benjamin
Journal:  Diabetes       Date:  1986-09       Impact factor: 9.461

10.  Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules.

Authors:  H S Teh; H Kishi; B Scott; H Von Boehmer
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  11 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  Low incidence of autoimmune type I diabetes in BB rats fed a hydrolysed casein-based diet associated with early inhibition of non-macrophage-dependent hyperexpression of MHC class I molecules on beta cells.

Authors:  X B Li; F W Scott; Y H Park; J W Yoon
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

3.  Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.

Authors:  A Fasano; S Uzzau
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

4.  Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens.

Authors:  K S Sellins; D P Gold; D Bellgrau
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

5.  Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat.

Authors:  A K Barlow; A A Like
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

6.  BB-DR/Edinburgh: a lymphopenic, non-diabetic subline of BB rats.

Authors:  S Joseph; A G Diamond; W Smith; J D Baird; G W Butcher
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

7.  Identification of a limited T-cell receptor beta chain variable region repertoire associated with diabetes in the BB rat.

Authors:  D P Gold; D Bellgrau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

8.  Allogeneic tumor-specific cytotoxic T lymphocytes.

Authors:  J M Redd; A C Lagarde; C A Kruse; D Bellgrau
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.

Authors:  L D Notarangelo; G Stoppoloni; R Toraldo; E Mazzolari; A Coletta; P Airò; C Bordignon; A G Ugazio
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

10.  Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma.

Authors:  C A Kruse; D H Mitchell; B K Kleinschmidt-DeMasters; D Bellgrau; J M Eule; J R Parra; Q Kong; K O Lillehei
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.